AI-generated summary
The authors studied whether low-level laser therapy combined with phloroglucinol could inhibit fibrosis in NIH/3T3 mouse fibroblast cells grown in the laboratory. The combined treatment reduced cell viability and proliferation and lowered markers of fibrosis more than either treatment alone, and the authors describe it as a possible alternative treatment. This was an in vitro study only, so the findings do not establish effects in people.
- Who or what was studied
- NIH/3T3 murine embryonic fibroblast cells cultured in vitro
- Limits stated in the abstract
- The study was performed in vitro on a single cell line, and the abstract does not report any animal or human testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.